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Workshop 4: Protein Folding and Stability
2833-Wkshp
Using proteins of reduced complexity to learn about cooperativity in
folding
Doug Barrick.
Johns Hopkins University, Baltimore, MD, USA.
2834-Wkshp
Prediction of protein functional states by multi-resolution protein
modeling
Cecilia Clementi.
Rice University, Houston, TX, USA.
2835-Wkshp
Alpha-Synuclein Conformation Affects Its Tyrosine Dependent Oxidative
Aggregation
Gary J. Pielak, Rebecca A.S. Ruf, Evan A.S. Lutz, Imola G. Zigoneanu.
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Oxidative stress and aggregation of the protein m-synuclein are thought to be
key factors in Parkinson’s disease. Previous work shows that cytochrome c
plus H2O2 causes tyrosine-dependant in vitro peroxidative aggregation of pro-
teins, including m-synuclein. Here, we examine the role of each of a-synu-
clein’s four tyrosine residues and how the protein’s conformation affects cova-
lent oxidative aggregation. When m-synuclein adopts a collapsed conformation,
tyrosine 39 is essential for wild-type-like covalent aggregation. This lone N-ter-
minal tyrosine, however, is not required for wild type-like covalent aggregation
in the presence of a denaturant or when m-synuclein is present in non-covalent
fibrils. We also show that pre-formed oxidative aggregates are not incorporated
into non-covalent fibrils. These data provide insight as to how dityrosine may
be formed in Lewy bodies seen in Parkinson’s disease.
2836-Wkshp
How Well Evolved Is The Folding Code?
Sheena Radford.
University of Leeds, Leeds, UK.
Proteins are thought to fold on rugged energy landscapes, most proteins folding
via kinetically trapped intermediates that accumulate as partially folded struc-
tures. Whilst such species may form essential stepping stones to the native
state, others may allow access to misfolding pathways. Key to understanding
the portioning between folding and misfolding, therefore, is to elucidate the
structures of partially folded intermediates and to identify features of such spe-
cies that favour correct folding or promote aberrant folding. Such information
is not only of fundamental importance, but underpins our quest to elucidate the
mechanism of chaperone action and the events that occur to tip the balance
between folding and aggregation. In an attempt to gain high resolution informa-
tion about the structure of intermediate species, we have used protein engineer-
ing, hydrogen exchange and chemical shift analysis, combined with restrained
molecular dynamics simulations to derive a model for the structure of an inter-
mediate formed during the folding of the four helical protein, Im7. More
recently, we have used these techniques to determine the mechanism for inter-
mediate formation, and hence the very earliest steps in folding wherein the na-
tive topology is formed. The data reveal an unusual ruggedness in the folding
landscape of this simple protein that we suggest results from the evolutionary
pressure to evolve new functions within this simple protein scaffold. In this lec-
ture these results will be described and the influence of functional restraints in
determining folding efficiency will be discussed.
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Effects Of Sequence And Conformational Contexts In Polyglutamine
Aggregation
Rohit Pappu.
Washington University, St. Louis, MO, USA.
Aggregation of proteins with expanded polyglutamine tracts is implicated in
the onset and progression of nine different neurodegenerative diseases includ-
ing Huntington’s disease. Recent work from our lab has focused on the driving
forces for polyglutamine aggregation. We have shown that water is a poor
solvent for polyglutamine. We have also shown that non-specific homotypic as-
sociations of collapsed albeit disordered polyglutamine molecules are sponta-
neous (non-nucleated), chain length dependent, and governed by the intrinsic
disorder (spontaneous fluctuations) of these molecules. In addition to a brief
overview of previous results, we will present results from recent work that
assesses the role of sequence contexts and conformational restraints on the ag-
gregation mechanisms of polyglutamine containing proteins. These results are
garnered from a combination of theoretical, computational, and experimental
efforts.
Workshop 5: Nanotechnology/Microfluidics
2838-Wkshp
Synthetic biology on the nanoscale
Petra Schwille.
Dresden University of Technology, Dresden, Germany.
2839-Wkshp
Fabrication Of Sealed Nanofluidic Channels Integrated With Surface
Electronics
Robert Austin1, Chih-kuan Tung2.
1Princeton University, Princeton, NJ, USA, 2Hong Kong Institute of Science
and Technology, Hong Kong, Hong Kong.
I will present a method to fabricate nanochannels which are integrated with
electronics using entirely room temperature processes. We believe this technol-
ogy will open the door to integration of many kinds of surface electronics with
nanochannel elongated polymer. The nanochannels are capped with a confor-
mal low auto-fluorescence polymer which enables us to perform single-mole-
cule optical imaging in real time with electronic detection.
2840-Wkshp
Nanostructures For Studying The Physics Of Biomolecules And Cells
Cees Dekker.
Delft University of Technology, Delft, Netherlands Antilles.
I will argue that nanostructures open up new opportunities for biophysics and
briefly present two examples: 1. We use fabricated nanopores to study DNA
and DNA-protein constructs. 2. Micro/nanofabricated chambers and channels
are used to study the motility and adaptive behavior of E. coli bacteria. I will re-
port the limits of bacterial penetration through narrow fabricated constrictions.
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Dynamic Liquid Film Interfaces
Owe Orwar.
Chalmers University of Technology, Go¨teborg, Sweden.
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Biology in Pico-Liter Droplets
Darren R. Link.
RainDance Technologies, Lexington, MA, USA.
RainDance Technologies is commercializing the use of picoliter droplets in mi-
crofluidic channels for applications in the life sciences. In typical applications,
cells, nucleic acids, enzymes, or other reagents are encapsulated in aqueous
phase droplets dispersed in a fluorinated carrier oil. These droplets range
from sub-picoliter to tens of nanoliters in volume, and are manipulated on an
individual basis to perform bioassays. Manipulations such as adding reagents
or sorting droplets based on their optical properties are achieved solely through
the application of external electric fields. Since electric fields can be turned on
or off at very high speeds, sorting rates exceeding several thousand per second
are readily achieved. We will focus on the techniques used to generate and ma-
nipulate droplets and introduce biological applications that are enabled by this
technology.
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